
Marawan A. Sayed, PhD
Postdoctoral Fellow in Neurology
- Address
-
GH 4700
NEUR
IN
Indianapolis, IN
Bio
Translational neuroscientist and pharmacologist with extensive experience in preclinical and in vivo models of neurological and systemic disease, biomarker discovery, and mechanism-of-action studies. Strong record of interdisciplinary collaboration spanning academia and translational research environments.
Key Publications
1-Seddiek, H., Hanna, M., Hamoud, A. E. M., Elbaset, M. A., Akabawy, A. M. A., Kotb, M. Z., & Khalifa, M. M. (2025). Deferiprone ameliorates cisplatin induced peripheral neurotoxicity via ferritinophagy adjustment. Sci. Rep., 15(1), 4485. https://doi.org/10.1038/s41598-025-87628-x.
Role: Designed and executed in vivo neuropharmacology experiments and contributed to mechanistic analysis of iron handling, ferritinophagy, and neuroprotection endpoints.
2- Hanna, M., Akabawy, A. M. A., Khalifa, M. M., Elbaset, M. A., Imam, R. A., & Seddiek, H. (2025). Intracellular iron accumulation throughout the progression of sepsis influences the phenotype and function of activated macrophages in renal tissue damage. Front. Physiol., 16. https://doi.org/10.3389/fphys.2025.1430946
Role: Contributed to experimental design, renal tissue analysis, and mechanistic interpretation of iron-dependent macrophage dysfunction during sepsis progression.
3- Elbaset, M. A., Afifi, S. M., Esatbeyoglu, T., Abdelrahman, S. S., & Saleh, D. O. (2024). Neuroprotective Effects of Trimetazidine against Cisplatin-Induced Peripheral Neuropathy: Involvement of AMPK-Mediated PI3K/mTOR, Nrf2, and NF-κB Signaling Axes. Oxidative Medicine and Cellular Longevity, 2024(1). https://doi.org/10.1155/2024/6612009.
Role: Led in vivo efficacy studies and contributed to signaling pathway analysis (AMPK-PI3K/mTOR, Nrf2, NF-κB) supporting mechanism-of-action conclusions.
4- Mahmoud, N. S., Elbaset, M. A., Mohawed, O. A. M., & Ahmed, H. H. (2024). Trimetazidine attenuates neuroinflammation via TLR4/NF-KB pathway inhibition in lipopolysaccharides-induced dementia in rats. Journal of Applied Pharmaceutical Science. https://doi.org/10.7324/JAPS.2024.166458.
Role: Conducted in vivo neuroinflammation experiments and contributed to pathway-focused analysis of TLR4/NF-κB signaling modulation.
5- Salem, E. M., Dawaba, H. M., Elbaset, M. A., Gad, S., & Hassan, T. H. (2024). Optimizing bioavailability and antihypertensive activity of Carvedilol cubosomes using D-optimal design: Comparative analysis of Cremophor RH 40 and Polyvinyl alcohol as secondary stabilizers. Journal of Drug Delivery Science and Technology, 97, 105817. https://doi.org/10.1016/j.jddst.2024.105817.
Role: Contributed to pharmacodynamic evaluation and in vivo efficacy assessment supporting formulation optimization.
8- S.A.E. Bashandy, A.M.A. El-Seidy, F.A.A. Ibrahim, S.S. Abdelrahman, S.A. Abdelmottaleb Moussa, M.A. ElBaset, Zinc nanoparticles ameliorated obesity-induced cardiovascular disease: role of metabolic syndrome and iron overload, Sci. Rep. 13 (2023) 16010. https://doi.org/10.1038/s41598-023-42550-y.
Role: Conducted in vivo cardiovascular pharmacology studies and contributed to metabolic and iron-overload mechanistic analyses.
9- N.F. Abdelkader, S.M. Ibrahim, P.E. Moustafa, M.A. Elbaset, Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways, Biomed. Pharmacother. 145 (2022) 112395. https://doi.org/10.1016/j.biopha.2021.112395.
Role: Performed in vivo neuropathy assessments and contributed to multi-pathway signaling analysis and data interpretation.
10- N.F. Abdelkader, M.A. Elbaset, P.E. Moustafa, S.M. Ibrahim, Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK. signaling, Arch. Pharm. Res. 45 (2022) 475–493. https://doi.org/10.1007/s12272-022-01391-5.
Role: Led in vivo efficacy studies and contributed to mechanistic evaluation of glucose-independent AMPK-mediated neuroprotection.
11- M. Hanna, H. Seddiek, B.E. Aboulhoda, G.N.B. Morcos, A.M.A. Akabawy, M.A. Elbaset, A.A. Ibrahim, M.M. Khalifa, I.M. Khalifah, M.S. Fadel, T. Shoukry, Synergistic cardioprotective effects of melatonin and deferoxamine through the improvement of ferritinophagy in doxorubicin-induced acute cardiotoxicity, Front. Physiol. 13 (2022). https://doi.org/10.3389/fphys.2022.1050598.
Role: Executed in vivo cardioprotection studies and contributed to ferritinophagy-focused mechanistic investigations.
11- N. Sharawy, A.A.A. Imam, B.E. Aboulhoda, M.M. Khalifa, G.N.B. Morcos, W.A. Abd Algaleel, P.E. Moustafa, M.A. Abdelbaset, T. Shoukry, Iron dyshomeostasis and time-course changes in iron-uptake systems and ferritin level in relation to pro-inflammatory microglia polarization in sepsis-induced encephalopathy, Front. Physiol. 13 (2022). https://doi.org/10.3389/fphys.2022.953206.
Role: Contributed to experimental design, neuroinflammation assessments, and interpretation of iron–microglia interaction dynamics.
| Year | Degree | Institution |
|---|---|---|
| 2020 | PhD | Cairo University |
| 2013 | MS | Cairo University |
| 2005 | BS | Cairo University |
• Translational in vivo pharmacology and biomarker-driven drug development
• Mechanism-of-action studies linking molecular signaling to functional outcomes
• Neuroinflammation, peripheral neuropathy, and CNS injury models
• Pharmacological modulation of metabolic–immune and iron-handling pathways
• Drug repurposing strategies with relevance to efficacy and safety optimization
Translational pharmacology approaches supporting therapeutic development in neurological, metabolic, and inflammatory disorders, with emphasis on treatment-related toxicity, biomarker-informed intervention strategies, and mechanism-based therapeutic optimization.